Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aranesp QW to Q2W Extension in Dialysis
NCT00436995Phase 3Completed
- Sponsor
- Amgen
- Start
- Apr 2006
- Primary completion
- Jan 2007
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Amgen. Started Apr 2006; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00436995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436995.